Why Biotechnology Investing is Looking Healthy

ETF Trends publisher Tom Lydon discussed SPDR S&P Biotech ETF (NYSEArca:XBI) on this week's "ETF of the Week" podcast with Chuck Jaffe on the MoneyLife Show. Deregulation/tax cuts from the Trump administration could help large biotechs accumulate more cash, which in turn could help fuel merger & acquisition activity in an ongoing low-rate environment. XBI tracks a… Click to read more at ETFtrends.com.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article was provided by our partner Tom Lydon of etftrends.com.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.